Skip to content

Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder

Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder: A Pilot Study and Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06239740
Acronym
ELECACU-COG-Pi
Enrollment
60
Registered
2024-02-02
Start date
2022-12-24
Completion date
2023-01-24
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Dysfunction, Major Depressive Disorders

Keywords

Electroacupuncture, Depression, Cognition, Humans, Pilot, Randomized Controlled Trial

Brief summary

The goal of this pilot Study and Randomized Controlled Trial is to investigate the impact of electroacupuncture on cognitive function, quality of life (QoL), and depression severity in patients with major depressive disorder (MDD). The main question\[s\] it aims to answer are: * Primary : electroacupuncture has the potential to treat subjective cognitive complaints and cognitive impairment in MDD outpatients * Secondary : electroacupuncture has the potential to treat depressive in MDD outpatients The 60 participants will randomly be assigned to either the treatment group or the control group in a 1:1 ratio. The treatment group will undergo electroacupuncture (EA), while the control group will receive sham acupuncture within 10 weeks period. Both groups will receive antidepressants with adjunctive medication (i.e., benzodiazepines, tricyclics, or antipsychotics) as the standard treatment. All participants will be assessed for executive functions and memory using specific cognitive tests, including the Trail Making Test B (TMT-B), Stroop Color and Word Test (SCWT), category delayed recall in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), and subjective reports of concern regarding concentration, memory, problem-solving, learning, communication, and quality of life (QoL) concerns using the WHO Disability Assessment Schedule (WHODAS 2.0; sections D1.1-1.6 and H1-3), and depressive symptoms were assessed using the Thai-PHQ-9.

Interventions

The acupuncture needle was placed on the scalp at a Chinese traditional acupuncture point. Subsequently, a small electrode was attached to the needle. A minor amount of electricity runs through the electrode, producing a slight vibration or soft hum during the treatment.

PROCEDURESham acupuncture

participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study

Sponsors

Thammasat University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

In the sham acupuncture control group (CG), participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study.

Intervention model description

In the electroacupuncture group (EG), participants received acupuncture at 10 scalp points (Baihui \[GV20\], Ex-hn 1, 3 points of intelligence \[Shenting \[GV24\], Benshen \[GB13\] on both sides, Touwei \[ST8\] on both sides). Electroacupuncture was applied for 20 minutes at Benshen \[GB13\] and Touwei \[ST8\] on both sides. They also received acupuncture at Tai chong \[LV3\], Tai Yuan \[LU9\], and Tai Xi \[KI3\] on both sides, as shown in picture 1. Acupuncture sessions were weekly for 10 weeks. In the sham acupuncture control group (CG), participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* aged between 18 and 55 years * MDD diagnosed according to the DSM-5 or DSM-IV-TR criteria, * low suicidal risk * receiving treatment with antidepressants for at least 3 months from psychiatrists and psychiatric residents. * Subjective cognitive symptoms from the screening using the Thai version of the Patient Health Questionnaire (Thai-PHQ-9).

Exclusion criteria

* severe cognitive deficits from traumatic brain injury, delirium, neurodevelopmental disorders, or intellectual disability; * neurological disorders such as stroke, Parkinson's disease, epilepsy, or other brain lesions; * severe medical conditions preventing lying down for 20 minutes; * recent electroconvulsive therapy (ECT) within the last 6 months; * Individuals with a pacemaker; * visual or hearing impairment that could not be corrected with eyeglasses or hearing aids; * severe MDD or scoring 20 points or more on the Thai-PHQ-9.

Design outcomes

Primary

MeasureTime frameDescription
Trail making test B (TMT-B)Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)The TMT- B is scored based on the time (in seconds) it takes to complete the test, including corrections for errors prompted by the examiner. A shorter time implies better performance.
The Stroop Color and Word Test (SCWT)Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)SCWT used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute.Score refers to the number of words achieved, and a higher number of words indicates a better score.
ADAS-cog category delayed recallPre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)ADAS-cog category delayed recall is used to assess memory. The score reflects the number of words that can be remembered. The more words remembered, the better the score.
Subjective cognitive complaintPre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)WHODAS 2.0; sections D1.1-1.6 and H1-3, which is a questionnaire asking about the number of days in the past 30 days when participants experienced difficulties with attention, understanding, and initiating conversation. Score is the rating of the number of days with issues, and a decrease in score indicates improvement or a better outcome.

Secondary

MeasureTime frameDescription
Thai Patient Health Questionnaire (PHQ-9)Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)The Thai PHQ-9 (Patient Health Questionnaire-9) objectifies and assesses degree of depression severity via questionnaire. A lower score means better.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026